Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial |
Reference |
Pseudomonas aeruginosa (cefpirome-resistant) |
12.5 |
100 |
3.13 - >100 |
Cefpirome + Syn2190 |
221 |
Pseudomonas aeruginosa (cefpirome-resistant) |
>100 |
>100 |
25 - >100 |
Cefpirome |
221 |
Pseudomonas aeruginosa (ceftadizime-resistant) |
>16 |
>32 |
? - ? |
Ceftobiprole (Zeftera) |
942 |
Pseudomonas aeruginosa (ceftadizime-susceptible) |
2 |
8 |
? - ? |
Ceftobiprole (Zeftera) |
942 |
Pseudomonas aeruginosa (ceftazidime-resistant) |
2 |
4 |
1 - 4 |
FR-264205 |
206 |
Pseudomonas aeruginosa (ceftazidime-resistant) |
2 |
8 |
0.063 - 16 |
S-4661 |
952 |
Pseudomonas aeruginosa (ceftazidime-resistant) |
2 |
64 |
≤0.0625 - >64 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
206 |
Pseudomonas aeruginosa (ceftazidime-resistant) |
4 |
16 |
0.063 - 32 |
Meropenem (Merrem) |
952 |
Pseudomonas aeruginosa (ceftazidime-resistant) |
6.25 |
12.5 |
1.56 - 50 |
Ceftazidime + Syn2190 |
221 |
Pseudomonas aeruginosa (ceftazidime-resistant) |
8 |
16 |
0.5 - 32 |
Imipenem |
952 |
Pseudomonas aeruginosa (ceftazidime-resistant) |
8 |
32 |
0.25 - 32 |
Biapenem |
952 |
Pseudomonas aeruginosa (ceftazidime-resistant) |
16 |
32 |
1 - 32 |
Imipenem |
206 |
Pseudomonas aeruginosa (ceftazidime-resistant) |
25 |
100 |
12.5 - >100 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
221 |
Pseudomonas aeruginosa (ceftazidime-resistant) |
32 |
128 |
32 - 128 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
952 |
Pseudomonas aeruginosa (ceftazidime-resistant) |
64 |
64 |
32 - >128 |
Cefpirome |
952 |
Pseudomonas aeruginosa (ceftazidime-resistant) |
64 |
128 |
32 - 128 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
206 |
Pseudomonas aeruginosa (ceftazidime-susceptible + imipenem-resistant) |
0.5 |
1 |
0.5 - 1 |
FR-264205 |
206 |
Pseudomonas aeruginosa (ceftazidime-susceptible + imipenem-resistant) |
1 |
8 |
0.0625 - 32 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
206 |
Pseudomonas aeruginosa (ceftazidime-susceptible + imipenem-resistant) |
4 |
16 |
1 - 16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
206 |
Pseudomonas aeruginosa (ceftazidime-susceptible + imipenem-resistant) |
- |
- |
16 - 64 |
Imipenem |
206 |
Pseudomonas aeruginosa (ceftazifime-resistant) |
>16 |
>64 |
? - ? |
Ceftobiprole (Zeftera) |
935 |
Pseudomonas aeruginosa (CIP 82.118) |
- |
- |
6 - ? |
Geranium sanguineum L. flower (Hexane extract) |
1497 |
Pseudomonas aeruginosa (CIP 82.118) |
- |
- |
6 - ? |
Geranium sanguineum L. flower (Methanol extract) |
1497 |
Pseudomonas aeruginosa (CIP 82.118) |
- |
- |
50 - ? |
Levofloxacin (Levaquin, Quixin) |
1497 |
Pseudomonas aeruginosa (CIP 82.118) |
- |
- |
1560 - ? |
Geranium sanguineum L. flower (Essential oil) |
1497 |
Pseudomonas aeruginosa (CIP 82.118) |
- |
- |
6000 - ? |
Geranium sanguineum L. flower (Dichloromethane extract) |
1497 |
Pseudomonas aeruginosa (CIP A22) |
- |
- |
20 - ? |
Bainem Algerian fresh myrtle leaf (Solvent-Free-Extraction essential oil) |
1586 |
Pseudomonas aeruginosa (ciprofloxacin-resistant) |
0.5 |
8 |
0.125 - 8 |
S-4661 |
952 |